New drugs in small-cell lung cancer

Interferons in the treatment of human cancer.

1984 • 334 citations

Lung Cancer: Progress in Therapeutic Research

1979 • 253 citations

Drug resistance in cancer.

1984 • 175 citations

VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules.

1978 • 166 citations

High dose methotrexate with leucovorin rescue

1980 • 153 citations

Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer.

1985 • 151 citations

Anticancer Drug Development

2009 • 95 citations

Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer.

1977 • 94 citations

Methylglyoxal-bis(guanylhydrazone) (Methyl-GAG): current status and future prospects.

1983 • 91 citations

High-dose cisplatin with fluid and mannitol-induced diuresis in advanced lung cancer: a phase II clinical trial of the EORTC Lung Cancer Working Party (Belgium).

1980 • 81 citations

VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer

1984 • 68 citations

Etoposide (VP-16) in the treatment of lung cancer

1983 • 50 citations

Ifosfamide: a weekly dose fractionated schedule in bronchogenic carcinoma.

1981 • 49 citations

Human leukocyte interferon as part of a combined treatment for previously untreated small cell lung cancer.

1985 • 33 citations

Human lymphoblastoid interferon in the treatment of small cell lung cancer

1983 • 32 citations

High-dose cisplatin for lung cancer.

1982 • 31 citations

Phase-II study with cis-dichlorodiammineplatinum (II) in small cell anaplastic bronchogenic carcinoma

1980 • 28 citations

Phase II study of teniposide in small cell carcinoma of the lung.

1984 • 25 citations

VM26 (NSC-122819): A clinical study in advanced cancer of the lung and ovary

1978 • 24 citations

Treatment of small cell bronchogenic carcinoma with VM-26.

1979 • 21 citations

Phase II trial of cisplatin in small cell carcinoma of the lung.

1981 • 21 citations

Phase II study on DON in patients with previously treated advanced lung cancer.

1982 • 19 citations

Phase II study of AMSA in lung cancer.

1981 • 19 citations

Phase II study of PALA, amsacrine, teniposide, and zinostatin in small cell lung carcinoma (EST 2579).

1984 • 18 citations

Phase II evaluation of PALA in patients with metastatic lung cancer.

1981 • 15 citations

Zinostatin (neocarzinostatin)

1979 • 15 citations

A Phase III Study in Lung Carcinoma Comparing Hexamethylmelamine (NSC 13875) to Dibromodulcitol (NSC 104800)

1975 • 15 citations

A clinico-pathologic correlation.

2007 • 14 citations

Procarbazine (NSC-77213) in the treatment of advanced bronchogenic carcinoma.

1969 • 14 citations

Phase II trial of vindesine in patients with small cell lung carcinoma.

1981 • 14 citations

Phase II evaluation of dianhydrogalactitol in lung cancer: a Southwest Oncology Group Study.

1981 • 14 citations

Phase II study of procarbazine in small cell carcinoma of the lung.

1982 • 13 citations

Phase II evaluation of AMSA in patients with metastatic lung cancer.

1980 • 12 citations

Phase II study of cisplatin, maytansine, and chlorozotocin in small cell lung carcinoma (EST 2578).

1982 • 11 citations

Hexamethylmelamine as a single agent in the treatment of small-cell carcinoma of the lung

1982 • 11 citations

Biology and Management of Lung Cancer

1983 • 10 citations

Lack of efficacy of high-dose methotrexate by 30-hour infusion in patients with progressive small cell carcinoma of the lung.

1982 • 9 citations

A phase II trial of vindesine in patients with refractory small-cell carcinoma of the lung

1982 • 8 citations

Phase II evaluation of mitoxantrone in patients with bronchogenic carcinoma: a Southeastern Cancer Study Group trial.

1984 • 8 citations

Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory small cell carcinoma of the lung

1983 • 8 citations

Streptozotocin in advanced small cell bronchogenic carcinoma: an ineffective nonmyelosuppressive agent.

1978 • 7 citations

Phase II trial of AMSA in patients with refractory small cell carcinoma of the lung.

1981 • 7 citations

Phase II study of vinblastine in small cell carcinoma of the lung.

1983 • 6 citations

A phase II trial of m-AMSA in patients with small-cell lung cancer.

1981 • 6 citations

Mitoxantrone for treatment of patients with refractory small cell carcinoma of the lung: a Southwest Oncology Group Study.

1983 • 6 citations

Phase II study of aclarubicin and diaziquone in the treatment of advanced small cell bronchogenic carcinoma (EST 4581): an Eastern Cooperative Oncology Group Study.

1985 • 5 citations

Phase II evaluation of triazinate in patients with metastatic lung cancer.

1980 • 5 citations

Intensive cytosine arabinoside therapy in small cell carcinoma of the lung

1984 • 3 citations

Phase II clinical trial with bisantrene in patients with advanced refractory small cell lung cancer.

1984 • 3 citations

Tumor Cloning Assay: Application and Potential Usefulness in Lung Cancer Management

1983 • 3 citations

Streptozotocin: an inactive agent in small cell carcinoma.

1979 • 3 citations

Phase II trial of mitoguazone in patients with relapsed small cell carcinoma of the lung.

1984 • 3 citations

A phase II clinical study of mAMSA in small cell carcinoma of the lung

1981 • 3 citations

Phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea in small cell cancer of the lung

1984 • 2 citations

Phase II trial of prednimustine (NSC-134087) in the treatment of small-cell anaplastic carcinoma of the lung

1980 • 2 citations

Phase II trial of mitomycin-C in patients with small cell carcinoma of the lung after failure on combination chemotherapy

1984 • 2 citations

Therapeutic Results on Small Cell Carcinoma of the Lung

1972 • 2 citations

Phase II evaluation of amsacrine in small cell lung cancer: a Southeastern Cancer Study Group trial.

1985 • 1 citations

Deleted Work

1955 • 0 citations